“ID: 2036 Next-generation sequencing to evaluate frequency of BCR-ABL1 kinase domain Imatinib-resistance mutations”, Biomed. Res. Ther., vol. 4, no. S, p. S67, Sep. 2017, doi: 10.15419/bmrat.v4iS.275.